The FGA gene helps make fibrinogen, a blood protein that helps your body form clots to stop bleeding after an injury. If this gene does not work properly, you may bleed more easily, and some people can also have blood clots form when they should not. Variants in the FGA gene are linked to inherited conditions with low, missing, or altered fibrinogen, which can lead to easy bruising, nosebleeds, heavy menstrual bleeding, or bleeding after surgery or childbirth.
What is a gene?
A gene is a section of DNA that holds instructions cells can use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do the work. Others mainly help direct when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in LearnHub.
Overview
FGAGene function
What if the gene works
The FGA gene helps make one part of fibrinogen, a blood clotting protein. This protein helps form a stable clot after injury, which limits bleeding and supports wound healing.
Risk
What if the gene does not work
Variants in the FGA gene can lower fibrinogen or change how it works, causing bruising, nosebleeds, or heavy periods. Milder variants may cause few symptoms, while more severe variants can lead to major bleeding and sometimes blood clots.
Treatment
What does that mean for your treatment
A pathogenic variant in the FGA gene that causes very low or absent fibrinogen usually makes fibrinogen replacement the key treatment, especially for bleeding, surgery, or childbirth. Fibrinogen concentrate is generally preferred, while cryoprecipitate or plasma may be used when concentrate is not available.
Conditions associated with FGA
Gene function
What if the gene works
When you get a cut, your body needs to stop blood loss while keeping the repair process orderly. The FGA gene helps make one part of fibrinogen, a blood protein that is central to forming a normal clot. This supports the first steps of wound sealing and everyday healing.
The FGA gene helps make the alpha part of fibrinogen, a blood protein that circulates until it is needed. When bleeding starts, fibrinogen is changed into fibrin, thread-like strands that begin sealing the injury.
Fibrinogen helps platelets, the small blood cells that gather at a wound, stick together. The alpha chain made from the FGA gene is part of this bridge, helping the early plug form in a controlled way.
The alpha chain also helps shape the final fibrin mesh so a clot has normal structure and hold. This is one of the main ways the FGA gene helps blood clotting during everyday healing.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FGA gene can alter the alpha part of fibrinogen, a blood clotting protein, so less protein is made, the protein is released poorly, or the final clot is weaker or less stable. When looking at how FGA gene variants affect fibrinogen, milder changes may leave some activity, while more severe variants can stop production almost completely. Some variants also change protein folding, which can lead to amyloid (misfolded protein deposits) in tissues.
How variants are linked to conditions
Pathogenic variants in the FGA gene can cause inherited fibrinogen conditions, including congenital afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia. These conditions may be linked to unusual bleeding, blood clots, or both, depending on the variant. Certain FGA variants also cause hereditary fibrinogen A alpha chain amyloidosis, a condition that mainly affects the kidneys. This is the main way FGA gene variants are linked to conditions in clinical genetics.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widespread in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FGA, risk is shaped mainly by the specific inherited gene change and whether one or both copies of the gene are affected. In people living with FGA-related fibrinogen conditions, surgery, injury, pregnancy, and blood-thinning medicines can raise bleeding risk, while some FGA changes can also raise clot risk, especially with immobility or estrogen-containing hormones.
Inheritance of FGA variants
The inheritance of FGA gene variants depends on the specific condition linked to the variant. Some FGA-related bleeding conditions, including congenital afibrinogenemia, usually follow an autosomal recessive pattern, which means a child inherits one altered copy from each parent. Other FGA-related conditions, such as some forms of dysfibrinogenemia and hereditary fibrinogen A α-chain amyloidosis, can follow an autosomal dominant pattern, so a variant in just one copy of the FGA gene may be enough to cause the condition. Because of this, how FGA gene variants are inherited can differ within the same gene.
What does my FGA result mean for my family?
For FGA, what it means for family members depends on the condition linked to the result. Some FGA changes are passed down in a dominant way, so a parent, child, brother, or sister may also carry the same change. Other FGA changes are linked to recessive conditions, which means relatives may be healthy carriers even if they do not have symptoms. Because FGA can follow more than one inheritance pattern, the family impact depends on the exact result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the FGA gene usually uses a blood or saliva sample, which a lab reads to look for changes in the DNA code. Results may confirm an inherited fibrinogen condition, clarify whether a known family variant is present, or show that no relevant variant was found.
When should I consider getting a genetic test?
Consider FGA testing if you or close relatives have unexplained bleeding, blood clots, repeated pregnancy loss, or blood tests showing very low or abnormal fibrinogen, a protein that helps blood clot. It can also help when a family member has a known FGA variant or an inherited fibrinogen condition.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or reacts to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body processes it. Understanding this can support more informed and individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the FGA gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or a personal or family history of unusual bleeding or blood clots are best discussed with your doctor.
History
Fibrinogen was identified in the 19th century as a key blood protein involved in clot formation, long before its genes were mapped. Initially understood only through visible traits, later recognized as tied to a specific gene, inherited fibrinogen conditions helped researchers connect unusual bleeding or clotting patterns within families to changes in the FGA gene. In the late 20th century, advances in molecular genetics allowed scientists to separate fibrinogen disorders into forms linked to FGA, FGB, and FGG. This helped explain why some families had low fibrinogen levels, while others made fibrinogen that did not work as expected. These historical steps shaped today’s understanding and made genetic testing more precise for inherited fibrinogen conditions.